164.35 -0.01%

1M-0.35% 1Y +0.03%   Market Closed

Analysts Review about Johnson & Johnson

Market Consensus (11 Analysts)

Buy

Price Target High -

Spread: -

Price Target Average -

Spread: -

Price Target Low -

Spread: -

Johnson & Johnson Among Trending Stocks For Second Week In A Row

J&J (JNJ) COVID-19 Vaccine Gets WHO's Emergency Listing

Technical Analyses Trend

Periods

Trend

Resistance

Support

Short Term

Neutral

132.43 (-18.67)

130.81 (-19.66)

Mid Term

Bullish

161.78(-0.64)

159.33(-2.15)

Long Term

Bearish

160.85(-1.22)

158.40 (-2.72)

  • 1W
  • 1M
  • 1Y
  • 5Y

Johnson & Johnson Articles

The Motley Fool

2 Top Value Stocks to Buy Right Now

These companies trade at attractive valuations compared to their long-term potential.

Sentiment: Positive 2021-03-14

Seeking Alpha

Week 11 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge

Two new breakout stocks for Week 11 of 2021 with better than 10% short-term upside potential. This past week both DSSI +11.4% and JNCE +27.1% gained more than 10% while the average return to the close for all 4 selections was a gain of +6.09%.

Sentiment: Positive 2021-03-13

Forbes

WHO Approves Johnson & Johnson's Covid Vaccine As Developing Countries Lag In Immunizations

The approval greenlights Johnson & Johnson's vaccine to start reaching dozens of low- and middle-income countries.

Sentiment: Positive 2021-03-12

SpStocks Review about Johnson & Johnson

SPS Rank 5th

SPS Note 8.5

SPS Consensus (08 Analysts) Buy

Target Price 0.00 USD -100.00%

Potentials Fair

Growth (Revenue) Extremely Poor

Finances Fair

Profitability Extremely Poor

Earnings Quality Extremely Poor

P/E Ratio Excellent

Valuation About Right

Fair Value 156.46USD -4.07%

Source

Sentiment

2021-03-12 J&J (JNJ) COVID-19 Vaccine Gets Conditional Approval in Europe

Za

Positive

2021-03-12 How Does Johnson & Johnson's COVID Vaccine Approval Affect Moderna?

Th

Neutral

2021-03-12 Biotech Stocks: What Will 2021 Look Like?

Th

Neutral

2021-03-12 7 of the Best Value Stocks on the Market Today

In

Positive

2021-03-11 Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Conditional Marketing Authorization by European Commission

Bu

Neutral

2021-03-11 5 Top Blue Chip Stocks to Buy as Dow Breezes Past 32,000

Za

Positive

2021-03-11 Johnson & Johnson Poised To Win European Approval For Its COVID-19 Vaccine

Be

Positive

2021-03-11 Europe's drug regulator has recommended the EU authorize Johnson and Johnson's COVID-19 vaccine (JNJ)

Bu

Positive

Johnson & Johnson Overview 30 Nov 2020

Johnson & Johnson Weight (JNJ) 0.04%

Open 162.6

High 162.83

Low 162.83

Change -1.52

Change Percent -0.01%

Close 162.83

Previous Close 164.35

Volume 7.23M

52 Week High 172.57

52 Week low 122.2

Gross Margin % %

Net Margin % %

Total Shares Outstanding

Market Capitalization 428.68B

Dividends

Dividends Paid (Last Quarter) The Company did not Pay Dividends

Dividends Paid (Last Fiscal Year)The Company did not Pay Dividends

Dividends Per Share (Last Quarter) The Company did not Pay Dividends

Dividends Yield (Last Fiscal Year) as of Today The Company did not Pay Dividends

Dividends Per Share (Last Fiscal Year) The Company did not Pay Dividends

Income Statement

Net Income (Last Fiscal Year) as per NA

1 year Revenue revision 82,584,000,000.00

4 months Revenue revision 29,038,000,000.00

4 months EPS revision

7 days EPS revision

1 Year Basic Before EPS (Last Fiscal Year)

1 Year Basic EPS Revision (Last Fiscal Year) as per